Collectively, our data underscore the pivotal role of P4 and EGF signaling cross-talk as well as the impact of PRA/PRB ratio for controlling key target genes such as HBEGF and AREG involved in breast cancer development and metastasis. The gene discussed is EGF; the disease is breast cancer.